Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will benefit most from our therapies.

Biotechnology

Education

Sensei Bio

John K. Celebi

Humberto Moran

Guolin Zhang

Cassie Fielding

Adejumoke Onumajuru

Donelson Smith

Michael Biega

Kristen Dougherty

Hanspeter Waldner

Bao Le

Thomas Thisted

Edward Van Der Horst

Christopher Gerry

Erin Colgan

The Research and Development team at Sensei Bio is dedicated to pioneering and advancing innovative immune therapies for cancer treatment. This multidisciplinary team collaborates on drug discovery, preclinical development, and clinical operations, utilizing a precision medicine approach to identify and optimize therapies that target specific patient populations. Their efforts are focused on translating scientific insights into effective treatment options for patients with various malignancies.

Research and Development

Corporate Governance

Advisory Team

��

Research and Development

About

Team members

Other teams at Sensei Bio

Corporate Governance

Advisory Team

��������

Research and Development

About

Team members

Other teams at Sensei Bio

Corporate Governance

Advisory Team

��